105 related articles for article (PubMed ID: 32279926)
1. Overrepresentation of highly functional T regulatory cells in patients with nonfunctioning pituitary adenoma.
Han S; Ma E; Jiang W; Lu Y; Sun X; Feng S
Hum Immunol; 2020 Jun; 81(6):314-319. PubMed ID: 32279926
[TBL] [Abstract][Full Text] [Related]
2. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
[TBL] [Abstract][Full Text] [Related]
3. Patients with intracranial aneurysms presented defects in regulatory T cells, which were associated with impairment in Tim-3 upregulation.
Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
Int Immunopharmacol; 2018 Nov; 64():350-355. PubMed ID: 30243071
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3.
Wang M; Liu C; Bond A; Yang J; Zhou X; Wang J; Ji B
Int Immunopharmacol; 2018 Jun; 59():53-60. PubMed ID: 29625390
[TBL] [Abstract][Full Text] [Related]
5. High levels of Tim-3
Zhong W; Liu X; Zhu Z; Li Q; Li K
Int Immunopharmacol; 2021 Jul; 96():107662. PubMed ID: 33864956
[TBL] [Abstract][Full Text] [Related]
6. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
7. Granzyme B-expressing treg cells are enriched in colorectal cancer and present the potential to eliminate autologous T conventional cells.
Sun B; Liu M; Cui M; Li T
Immunol Lett; 2020 Jan; 217():7-14. PubMed ID: 31669380
[TBL] [Abstract][Full Text] [Related]
8. Soluble galectin 9 potently enhanced regulatory T-cell formation, a pathway impaired in patients with intracranial aneurysm.
Zhao MG; Liang GB; Zhang HF; Zhao GF; Luo YH
Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1206-1212. PubMed ID: 29978574
[TBL] [Abstract][Full Text] [Related]
9. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.
Gautron AS; Dominguez-Villar M; de Marcken M; Hafler DA
Eur J Immunol; 2014 Sep; 44(9):2703-2711. PubMed ID: 24838857
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells demonstrate significantly increased functions following stimulation with IL-2 in a Tim-3-dependent manner in intracranial aneurysms.
Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
Int Immunopharmacol; 2018 Dec; 65():342-347. PubMed ID: 30366277
[TBL] [Abstract][Full Text] [Related]
11. Alterations in CD8
Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
[TBL] [Abstract][Full Text] [Related]
12. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
13. Tim3
Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
[TBL] [Abstract][Full Text] [Related]
14. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
[TBL] [Abstract][Full Text] [Related]
15. Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment.
Banerjee H; Nieves-Rosado H; Kulkarni A; Murter B; McGrath KV; Chandran UR; Chang A; Szymczak-Workman AL; Vujanovic L; Delgoffe GM; Ferris RL; Kane LP
Cell Rep; 2021 Sep; 36(11):109699. PubMed ID: 34525351
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Potential Markers of Regulatory and Exhausted CD8
Naghavi Alhosseini M; Palazzo M; Cari L; Ronchetti S; Migliorati G; Nocentini G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901957
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
[TBL] [Abstract][Full Text] [Related]
18. Modulation of adipose tissue inflammation by FOXP3+ Treg cells, IL-10, and TGF-β in metabolically healthy class III obese individuals.
Pereira S; Teixeira L; Aguilar E; Oliveira M; Savassi-Rocha A; Pelaez JN; Capettini L; Diniz MT; Ferreira A; Alvarez-Leite J
Nutrition; 2014; 30(7-8):784-90. PubMed ID: 24984993
[TBL] [Abstract][Full Text] [Related]
19. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
20. Decreased frequencies and impaired functions of the CD31
Huang L; Zheng Y; Yuan X; Ma Y; Xie G; Wang W; Chen H; Shen L
Clin Exp Immunol; 2017 Mar; 187(3):441-454. PubMed ID: 27997991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
